A Gift for You: the Agilent 2015 Calendar

141218 calendarAmong Agilent’s biggest strengths are the talent, diversity and innovative ideas of its 12,000 employees around the world.

One way Agilent fosters its sense of community, culture and diversity is through its monthly photo contest for employees, by employees.  Photographers are encouraged to share their different perspectives and creativity.  Their only reward is recognition by fellow employees…

… and the Agilent calendar.  Once a year, we take a sampling of the best photos – and the stories behind them – and compile them in a downloadable calendar.

We are pleased to share the 2015 calendar with all of you, our families and friends of Agilent.

To download the file, right-click on the link below and save it to your hard drive (“save target as”).

To print the file, open it using Adobe Acrobat. For better printing results, you can bring the file to your local commercial printer. The calendar is optimized for printing on 8.5 x 11 inch (“letter”) paper, printed on both sides.

As the Agilent Technologies Blog takes a break for the rest of December, we wish all of you a joyous holiday season and a Happy New Year.


For more information go to:

Filed Under: All, Corporate
Tags: ,

Agilent in Pharmaceuticals

Agilent helps uncover what causes diseases and how to treat them

Agilent helps uncover what causes diseases and how to treat them

In 2012, there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer worldwide.  Although the number of cases is increasing, more people are surviving the disease.  One reason is earlier detection and more effective drugs.

Agilent’s tools for analyzing DNA, RNA, proteins and metabolites have played an important role in the understanding and treatment of cancer.  Agilent also works with pharmaceutical companies and researchers to advance treatment of cardiovascular disease and development disorders such as autism.

There are five major areas of pharma where Agilent helps customers gain new insights.

Finding out what causes the disease.  Agilent’s genomic solutions, liquid chromatography (LC) and mass spectrometry (MS) platforms are used extensively to measure DNA, proteins and metabolites.  Agilent’s GeneSpring Pathway Architecture software can pull data together from many sources.  This helps pharma researchers understand the detailed molecular basis for disease.

Drug discovery.  Agilent’s RapidFire MS product helps pharma scientists identify drugs that interact most strongly with desired targets.  New biological drugs demonstrate many advantages over traditional chemical drugs, and Agilent is at the forefront of this trend.

R&D and drug development.  Pharma labs must ensure that a new drug works, that it is safe and stable, and that its results are consistent and reproducible.  Agilent LC, optical and MS solutions help pharma researchers validate their drug candidate – or as is often the case, realize it is time to go back to drug discovery.  Agilent is also the leader in ultra-high-pressure liquid chromatography (UHPLC), which can acquire better data in less time.

Clinical trials.  With a candidate drug now in hand, scientists want to know how well it will work on patients.  With the acquisition of Dako, Agilent is now a leader in immunohistochemistry – a method of testing tumor tissue based on how it responds to various protein-based staining reagents.  Agilent SureSelect Target Enrichment kits can also classify tumor properties, based on DNA sequencing.

Informatics and services.  In a highly competitive industry, the management and protection of information about the next potential blockbuster drug is critical.  Agilent’s OpenLAB software is used by 10 of the world’s top 11 pharmaceutical companies to create, collaborate, archive and re-use business-critical information easily and securely.

Agilent’s customer markets include energy and chemicals, food, the environment, forensics, pharmaceuticals, research and diagnostics.


For more information go to:

Filed Under: All, Chemical Analysis, Life Sciences
Tags: , , , , , , , , , , , ,

Can Mice Help Your Acne?

Mice have been bioengineered to aid in acne research

Mice have been bioengineered to aid in acne research

Acne is a common skin disease that affects a majority of people, particularly in western countries.  It is especially prevalent during adolescence, when teenagers undergo rapid hormonal changes.

Acne is unique to humans, as most animals do not produce triglycerides in their hair follicles.  This makes it difficult to conduct research into the disease.

A team of scientists in the U.S. and Germany successfully used bioengineering to mimic an in vivo microenvironment of acne lesions in mice.  By implanting human tissue containing triglyceride-producing glands into mice, they were able to induce an immune response that mimicked an acne inflammation.  They were able to study the interactions of bacteria and proteins within the host biological environment.

The researchers used an Agilent liquid chromatograph and Agilent columns in their work.

This information is for research purposes only.  It is not intended for any use in diagnostic procedures.


For more information go to:

Filed Under: All, Life Sciences
Tags: , ,

Please visit the Archive for more news items.

Agilent Request Form

For product or company information, please fill in all required fields.

Agilent Request Form

For product or company information, please fill in all required fields.

   
Name:
Email:
Phone:
Message:

Please leave this field empty.
captcha